Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan NK Cell Therapy market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan NK Cell Therapy market. Detailed analysis of key players, along with key growth strategies adopted by NK Cell Therapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Affimed NV (Netherlands)
NantKwest Inc (USA)
Bristol-Myers Squibb (USA)
Sorrento Therapeutics Inc. (USA)
Takeda Pharmaceutical (Japan)
Chipscreen Biosciences (China)
Sorrento Therapeutics Inc (USA)
Innate Pharma SA (France)
NantKwest Inc. (USA)
By Type:
Mogamulizumab
Lorvotuzumab Mertansine
Others
By End-User:
Cancer
Cardiovascular Diseases
Others
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of NK Cell Therapy Market
-
1.3 Market Segment by Type
1.3.1 Japan NK Cell Therapy Market Size and Growth Rate of Mogamulizumab from 2014 to 2026
1.3.2 Japan NK Cell Therapy Market Size and Growth Rate of Lorvotuzumab Mertansine from 2014 to 2026
1.3.3 Japan NK Cell Therapy Market Size and Growth Rate of Others from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan NK Cell Therapy Market Size and Growth Rate of Cancer from 2014 to 2026
1.4.2 Japan NK Cell Therapy Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026
1.4.3 Japan NK Cell Therapy Market Size and Growth Rate of Others from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido NK Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku NK Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto NK Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu NK Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki NK Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku NK Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku NK Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu NK Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of NK Cell Therapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of NK Cell Therapy by Major Types
3.4.1 Market Size and Growth Rate of Mogamulizumab
3.4.2 Market Size and Growth Rate of Lorvotuzumab Mertansine
3.4.3 Market Size and Growth Rate of Others
4 Segmentation of NK Cell Therapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of NK Cell Therapy by Major End-Users
4.4.1 Market Size and Growth Rate of NK Cell Therapy in Cancer
4.4.2 Market Size and Growth Rate of NK Cell Therapy in Cardiovascular Diseases
4.4.3 Market Size and Growth Rate of NK Cell Therapy in Others
5 Market Analysis by Regions
-
5.1 Japan NK Cell Therapy Production Analysis by Regions
-
5.2 Japan NK Cell Therapy Consumption Analysis by Regions
6 Hokkaido NK Cell Therapy Landscape Analysis
-
6.1 Hokkaido NK Cell Therapy Landscape Analysis by Major Types
-
6.2 Hokkaido NK Cell Therapy Landscape Analysis by Major End-Users
7 Tohoku NK Cell Therapy Landscape Analysis
-
7.1 Tohoku NK Cell Therapy Landscape Analysis by Major Types
-
7.2 Tohoku NK Cell Therapy Landscape Analysis by Major End-Users
8 Kanto NK Cell Therapy Landscape Analysis
-
8.1 Kanto NK Cell Therapy Landscape Analysis by Major Types
-
8.2 Kanto NK Cell Therapy Landscape Analysis by Major End-Users
9 Chubu NK Cell Therapy Landscape Analysis
-
9.1 Chubu NK Cell Therapy Landscape Analysis by Major Types
-
9.2 Chubu NK Cell Therapy Landscape Analysis by Major End-Users
10 Kinki NK Cell Therapy Landscape Analysis
-
10.1 Kinki NK Cell Therapy Landscape Analysis by Major Types
-
10.2 Kinki NK Cell Therapy Landscape Analysis by Major End-Users
11 Chugoku NK Cell Therapy Landscape Analysis
-
11.1 Chugoku NK Cell Therapy Landscape Analysis by Major Types
-
11.2 Chugoku NK Cell Therapy Landscape Analysis by Major End-Users
12 Shikoku NK Cell Therapy Landscape Analysis
-
12.1 Shikoku NK Cell Therapy Landscape Analysis by Major Types
-
12.2 Shikoku NK Cell Therapy Landscape Analysis by Major End-Users
13 Kyushu NK Cell Therapy Landscape Analysis
-
13.1 Kyushu NK Cell Therapy Landscape Analysis by Major Types
-
13.2 Kyushu NK Cell Therapy Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Affimed NV (Netherlands)
14.1.1 Affimed NV (Netherlands) Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 NantKwest Inc (USA)
14.2.1 NantKwest Inc (USA) Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Bristol-Myers Squibb (USA)
14.3.1 Bristol-Myers Squibb (USA) Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Sorrento Therapeutics Inc. (USA)
14.4.1 Sorrento Therapeutics Inc. (USA) Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Takeda Pharmaceutical (Japan)
14.5.1 Takeda Pharmaceutical (Japan) Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Chipscreen Biosciences (China)
14.6.1 Chipscreen Biosciences (China) Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Sorrento Therapeutics Inc (USA)
14.7.1 Sorrento Therapeutics Inc (USA) Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Innate Pharma SA (France)
14.8.1 Innate Pharma SA (France) Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 NantKwest Inc. (USA)
14.9.1 NantKwest Inc. (USA) Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
The List of Tables and Figures (Totals 126 Figures and 136 Tables)
Figure Japan NK Cell Therapy Market Size and Growth Rate of Mogamulizumab from 2014 to 2026
Figure Japan NK Cell Therapy Market Size and Growth Rate of Lorvotuzumab Mertansine from 2014 to 2026
Figure Japan NK Cell Therapy Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan NK Cell Therapy Market Size and Growth Rate of Cancer from 2014 to 2026
Figure Japan NK Cell Therapy Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026
Figure Japan NK Cell Therapy Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido NK Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku NK Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto NK Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu NK Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki NK Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku NK Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku NK Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu NK Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of NK Cell Therapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of NK Cell Therapy
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of NK Cell Therapy by Different Types from 2014 to 2026
-
Table Consumption Share of NK Cell Therapy by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Mogamulizumab
Figure Market Size and Growth Rate of Lorvotuzumab Mertansine
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of NK Cell Therapy by Different End-Users from 2014 to 2026
-
Table Consumption Share of NK Cell Therapy by Different End-Users from 2014 to 2026
Figure Japan NK Cell Therapy Market Size and Growth Rate of Cancer from 2014 to 2026
Figure Japan NK Cell Therapy Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026
Figure Japan NK Cell Therapy Market Size and Growth Rate of Others from 2014 to 2026
-
Table Japan NK Cell Therapy Production by Regions
-
Table Japan NK Cell Therapy Production Share by Regions
-
Figure Japan NK Cell Therapy Production Share by Regions in 2014
-
Figure Japan NK Cell Therapy Production Share by Regions in 2018
-
Figure Japan NK Cell Therapy Production Share by Regions in 2026
-
Table Japan NK Cell Therapy Consumption by Regions
-
Table Japan NK Cell Therapy Consumption Share by Regions
-
Figure Japan NK Cell Therapy Consumption Share by Regions in 2014
-
Figure Japan NK Cell Therapy Consumption Share by Regions in 2018
-
Figure Japan NK Cell Therapy Consumption Share by Regions in 2026
-
Table Hokkaido NK Cell Therapy Consumption by Types from 2014 to 2026
-
Table Hokkaido NK Cell Therapy Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido NK Cell Therapy Consumption Share by Types in 2014
-
Figure Hokkaido NK Cell Therapy Consumption Share by Types in 2018
-
Figure Hokkaido NK Cell Therapy Consumption Share by Types in 2026
-
Table Hokkaido NK Cell Therapy Consumption by End-Users from 2014 to 2026
-
Table Hokkaido NK Cell Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido NK Cell Therapy Consumption Share by End-Users in 2014
-
Figure Hokkaido NK Cell Therapy Consumption Share by End-Users in 2018
-
Figure Hokkaido NK Cell Therapy Consumption Share by End-Users in 2026
-
Table Tohoku NK Cell Therapy Consumption by Types from 2014 to 2026
-
Table Tohoku NK Cell Therapy Consumption Share by Types from 2014 to 2026
-
Figure Tohoku NK Cell Therapy Consumption Share by Types in 2014
-
Figure Tohoku NK Cell Therapy Consumption Share by Types in 2018
-
Figure Tohoku NK Cell Therapy Consumption Share by Types in 2026
-
Table Tohoku NK Cell Therapy Consumption by End-Users from 2014 to 2026
-
Table Tohoku NK Cell Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku NK Cell Therapy Consumption Share by End-Users in 2014
-
Figure Tohoku NK Cell Therapy Consumption Share by End-Users in 2018
-
Figure Tohoku NK Cell Therapy Consumption Share by End-Users in 2026
-
Table Kanto NK Cell Therapy Consumption by Types from 2014 to 2026
-
Table Kanto NK Cell Therapy Consumption Share by Types from 2014 to 2026
-
Figure Kanto NK Cell Therapy Consumption Share by Types in 2014
-
Figure Kanto NK Cell Therapy Consumption Share by Types in 2018
-
Figure Kanto NK Cell Therapy Consumption Share by Types in 2026
-
Table Kanto NK Cell Therapy Consumption by End-Users from 2014 to 2026
-
Table Kanto NK Cell Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto NK Cell Therapy Consumption Share by End-Users in 2014
-
Figure Kanto NK Cell Therapy Consumption Share by End-Users in 2018
-
Figure Kanto NK Cell Therapy Consumption Share by End-Users in 2026
-
Table Chubu NK Cell Therapy Consumption by Types from 2014 to 2026
-
Table Chubu NK Cell Therapy Consumption Share by Types from 2014 to 2026
-
Figure Chubu NK Cell Therapy Consumption Share by Types in 2014
-
Figure Chubu NK Cell Therapy Consumption Share by Types in 2018
-
Figure Chubu NK Cell Therapy Consumption Share by Types in 2026
-
Table Chubu NK Cell Therapy Consumption by End-Users from 2014 to 2026
-
Table Chubu NK Cell Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu NK Cell Therapy Consumption Share by End-Users in 2014
-
Figure Chubu NK Cell Therapy Consumption Share by End-Users in 2018
-
Figure Chubu NK Cell Therapy Consumption Share by End-Users in 2026
-
Table Kinki NK Cell Therapy Consumption by Types from 2014 to 2026
-
Table Kinki NK Cell Therapy Consumption Share by Types from 2014 to 2026
-
Figure Kinki NK Cell Therapy Consumption Share by Types in 2014
-
Figure Kinki NK Cell Therapy Consumption Share by Types in 2018
-
Figure Kinki NK Cell Therapy Consumption Share by Types in 2026
-
Table Kinki NK Cell Therapy Consumption by End-Users from 2014 to 2026
-
Table Kinki NK Cell Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki NK Cell Therapy Consumption Share by End-Users in 2014
-
Figure Kinki NK Cell Therapy Consumption Share by End-Users in 2018
-
Figure Kinki NK Cell Therapy Consumption Share by End-Users in 2026
-
Table Chugoku NK Cell Therapy Consumption by Types from 2014 to 2026
-
Table Chugoku NK Cell Therapy Consumption Share by Types from 2014 to 2026
-
Figure Chugoku NK Cell Therapy Consumption Share by Types in 2014
-
Figure Chugoku NK Cell Therapy Consumption Share by Types in 2018
-
Figure Chugoku NK Cell Therapy Consumption Share by Types in 2026
-
Table Chugoku NK Cell Therapy Consumption by End-Users from 2014 to 2026
-
Table Chugoku NK Cell Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku NK Cell Therapy Consumption Share by End-Users in 2014
-
Figure Chugoku NK Cell Therapy Consumption Share by End-Users in 2018
-
Figure Chugoku NK Cell Therapy Consumption Share by End-Users in 2026
-
Table Shikoku NK Cell Therapy Consumption by Types from 2014 to 2026
-
Table Shikoku NK Cell Therapy Consumption Share by Types from 2014 to 2026
-
Figure Shikoku NK Cell Therapy Consumption Share by Types in 2014
-
Figure Shikoku NK Cell Therapy Consumption Share by Types in 2018
-
Figure Shikoku NK Cell Therapy Consumption Share by Types in 2026
-
Table Shikoku NK Cell Therapy Consumption by End-Users from 2014 to 2026
-
Table Shikoku NK Cell Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku NK Cell Therapy Consumption Share by End-Users in 2014
-
Figure Shikoku NK Cell Therapy Consumption Share by End-Users in 2018
-
Figure Shikoku NK Cell Therapy Consumption Share by End-Users in 2026
-
Table Kyushu NK Cell Therapy Consumption by Types from 2014 to 2026
-
Table Kyushu NK Cell Therapy Consumption Share by Types from 2014 to 2026
-
Figure Kyushu NK Cell Therapy Consumption Share by Types in 2014
-
Figure Kyushu NK Cell Therapy Consumption Share by Types in 2018
-
Figure Kyushu NK Cell Therapy Consumption Share by Types in 2026
-
Table Kyushu NK Cell Therapy Consumption by End-Users from 2014 to 2026
-
Table Kyushu NK Cell Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu NK Cell Therapy Consumption Share by End-Users in 2014
-
Figure Kyushu NK Cell Therapy Consumption Share by End-Users in 2018
-
Figure Kyushu NK Cell Therapy Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Affimed NV (Netherlands)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Affimed NV (Netherlands)
Figure Sales and Growth Rate Analysis of Affimed NV (Netherlands)
Figure Revenue and Market Share Analysis of Affimed NV (Netherlands)
Table Product and Service Introduction of Affimed NV (Netherlands)
Table Company Profile and Development Status of NantKwest Inc (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of NantKwest Inc (USA)
Figure Sales and Growth Rate Analysis of NantKwest Inc (USA)
Figure Revenue and Market Share Analysis of NantKwest Inc (USA)
Table Product and Service Introduction of NantKwest Inc (USA)
Table Company Profile and Development Status of Bristol-Myers Squibb (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb (USA)
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb (USA)
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb (USA)
Table Product and Service Introduction of Bristol-Myers Squibb (USA)
Table Company Profile and Development Status of Sorrento Therapeutics Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sorrento Therapeutics Inc. (USA)
Figure Sales and Growth Rate Analysis of Sorrento Therapeutics Inc. (USA)
Figure Revenue and Market Share Analysis of Sorrento Therapeutics Inc. (USA)
Table Product and Service Introduction of Sorrento Therapeutics Inc. (USA)
Table Company Profile and Development Status of Takeda Pharmaceutical (Japan)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical (Japan)
Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical (Japan)
Figure Revenue and Market Share Analysis of Takeda Pharmaceutical (Japan)
Table Product and Service Introduction of Takeda Pharmaceutical (Japan)
Table Company Profile and Development Status of Chipscreen Biosciences (China)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chipscreen Biosciences (China)
Figure Sales and Growth Rate Analysis of Chipscreen Biosciences (China)
Figure Revenue and Market Share Analysis of Chipscreen Biosciences (China)
Table Product and Service Introduction of Chipscreen Biosciences (China)
Table Company Profile and Development Status of Sorrento Therapeutics Inc (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sorrento Therapeutics Inc (USA)
Figure Sales and Growth Rate Analysis of Sorrento Therapeutics Inc (USA)
Figure Revenue and Market Share Analysis of Sorrento Therapeutics Inc (USA)
Table Product and Service Introduction of Sorrento Therapeutics Inc (USA)
Table Company Profile and Development Status of Innate Pharma SA (France)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Innate Pharma SA (France)
Figure Sales and Growth Rate Analysis of Innate Pharma SA (France)
Figure Revenue and Market Share Analysis of Innate Pharma SA (France)
Table Product and Service Introduction of Innate Pharma SA (France)
Table Company Profile and Development Status of NantKwest Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of NantKwest Inc. (USA)
Figure Sales and Growth Rate Analysis of NantKwest Inc. (USA)
Figure Revenue and Market Share Analysis of NantKwest Inc. (USA)
Table Product and Service Introduction of NantKwest Inc. (USA)
-
